Introduction
myocardial ischemia. If the concept of a causative role of inflammation, especially PMN accumulation and activaThe presence of inflammatory cells in the ischemic tion, in ischemic heart disease (IHD) is proven, antimyocardial tissues has traditionally been believed to inflammatory therapy may be designed to prevent and treat represent pathophysiologic response to injury [1] . It is only this common malady. recently that inflammation has been related to the pathogenesis of acute coronary syndromes [2, 3] , reperfusion injury to ischemic myocardium [4] , restenosis after angiop-2. Role of inflammation in atherogenesis lasty [5] [6] [7] , failure of cardiac transplant [8] , and chronic heart failure [9] . Accordingly, the relationship between Several risk factors, such as hypertension, diabetes inflammation with atherosclerosis and myocardial ischemia mellitus, dyslipidemia and smoking, are often associated is now an area of active investigation.
with atherosclerosis. However, precise steps leading to Accumulation of polymorphonuclear leukocytes (PMN) atherosclerosis remain elusive. Work from several laband their activation are key features of inflammatory oratories in animal models of atherosclerosis, primarily in reaction associated with acute myocardial ischemia-reresponse to feeding a high cholesterol diet, has suggested perfusion [3] . Experimental studies have shown that influx that endothelium becomes activated and dysfunctional of PMNs into tissues results in tissue injury beyond that early in the course of atherosclerosis [20] . The classic caused by ischemia alone [10, 11] . It has also become endothelial dysfunction, i.e. vasoconstriction and cellular apparent that the recruitment of PMNs during ischemiadeposition on the intima, is thought to be related to a reperfusion involves numerous mediators [3, 4] . The causareduction in the generation of vasodilator species nitric tive role of PMNs in reperfusion injury in animals is oxide (NO) [21] . Although initial studies suggested disupported by the observations of reduction in microvascuminished generation of another potent vasodilator species lar dysfunction and tissue injury by strategies that prevent prostacyclin (PGI ), subsequent studies indicated that the 2 PMN influx in tissues by either a decrease in the number cholesterol-laden blood vessels actually released more of circulating PMNs [12] , or prevent PMN activation [13] .
arachidonic acid than the normal blood vessels and had Other studies [14] and T-lymphocytes on the endothelium as cholesterol In this report, we review our current understanding of feeding of animal continues. Work from our laboratory inflammation in myocardial ischemia in patients with [24] has shown that oxidized-LDL-treated rat endothelial cells exhibit P-selectin expression well before a functional insufficiency of NO becomes evident, and these endothelifactors derived from endothelial cells, platelets, vascular al cells allow deposition of large number of inflammatory smooth muscle cells and inflammatory cells, and their cells. However, inhibition of NO per se decidedly facilinormal side-to-side smooth pattern becomes disarrayed, tates deposition of inflammatory cells [25] .
resulting in inward folding of vascular lining. In the During the course of cholesterol feeding to the animals, process of enlarging fatty streak, complex atherosclerotic monocytes traverse the intercellular space and are delesions (fibrous plaque) form when there is disruption of posited in the subendothelial layers where they are transendothelial lining with exposure of subendothelial collagen formed into macrophages, and a 'fatty streak' is formed.
and deposition and activation of platelets, resulting in These and subsequent steps are graphically shown in Fig. thrombotic narrowing of the lumen. Thrombin and factor 1. Vascular smooth muscle cells undergo hypertrophy and Xa in this setting may also stimulate a procoagulant state. hyperplasia in response to a variety of growth promoting
The uncontrolled growth of various components of the Fig. 1 . Postulated steps in atherogenesis showing a critical role of inflammation in the development of fatty streak, progressive atherosclerotic lesion and development of an occlusive thrombus following plaque rupture in the atherosclerotic coronary artery (A-E). Note that repeated episodes of thrombosis and reperfusion lead to incorporation of the thrombus in the atheroma. During reperfusion there is intense activation of the endothelium with deposition and infiltration of leukocytes in the vessel wall and underlying myocardium. Inflammation leads to further progression of atherosclerosis in the ischemicreperfused coronary artery (F).
vessel wall leads to a reduction in the arterial lumen and thelial and smooth muscle injury, and capillary leakage [4] . tissue ischemia.
Release of ROS has been shown to stimulate release of During various stages of atherogenesis, there is expresproteolytic enzymes [38] . sion of various cytokines such as tumor necrosis factorThrombus formed in the narrowed coronary artery upon alpha (TNFa), interleukins (ILs), interferon-g (IFN-g) and plaque rupture often undergoes spontaneous lysis, and part macrophage colony stimulating factor (MCSF) [26] [27] [28] .
of the thrombus becomes part of the atheroma (see Fig. 1 ). These cytokines induce smooth muscle cells to express Reperfusion is associated with acute inflammation and interstitial collagenase and stromelysin [27, 29] , and the activation of endothelial cells, platelets and white blood degradation of collagen results in thinning of the blood cells. There is marked release of cytokines in the ischemicvessel and its outward bulging. Cytokines expressed in the reperfused myocardium, at least in part by activation of vessel walls are potent chemoattractants for inflammatory mast cells [39] . The number of mast cells continues to cells (including macrophages and T-cells and PMNs), increase during the healing phase [40] , which attract more induce expression of adhesion molecules on the endoleukocytes and induce their activation in the region supthelium and their counterligands on the leukocytes, proplied by the ischemic-reperfused artery. The state of mote platelet activity and thrombosis, and inhibit thromleukocyte deposition may be the basis of rapid progression bolysis [30] . Recently an important role for CD40 sigof atherosclerosis in these regions. naling and its ligand CD40L has also been suggested in atherogenesis. CD40 is a member of TNF receptor family of receptors, and the cells in atherosclerotic regions 3. Inflammation in precipitation of acute myocardial express CD40 and CD40L (also known as CD154 or ischemia gp39). In an interesting study [31] , administration of a neutralizing anti-CD40L monoclonal antibody to high Acute myocardial ischemia generally results from acute cholesterol-fed mice decreased the size of atherosclerotic occlusion of the atherosclerotic coronary artery by a lesions, the number of macrophages and T-lymphocytes, platelet-rich thrombus. The occlusion may be transient and and expression of vascular cell adhesion molecule episodic resulting in the syndrome of unstable angina, or (VCAM-1).
firm and permanent resulting in myocyte death (infarction). Studies in many laboratories have shown that it is the The thrombus formation occurs at the site of atherosoxidatively modified low density lipoprotein (ox-LDL) clerotic plaque rupture or hemorrhage into the plaque with which is taken up by monocytes / macrophages via the subsequent break in endothelial integrity [41] . Current scavenger receptors on surface. Oxidation of LDL can evidence suggests that inflammation is involved in plaque occur in endothelial cells, platelets and inflammatory cells.
rupture and the biology of thrombosis. It is the ox-LDL that is recognized by newly-described
In classic pathologic studies in patients who died of unique lectin-like receptors (LOX-1) on the human arterial acute myocardial ischemia, van der Wal et al. [42] found endothelial cells. Incubation of endothelial cells with oxthat macrophages and T-lymphocytes were the dominant LDL further facilitates the expression of LOX-1 [32] , cell types at the immediate site of either rupture or results in formation and release of reactive oxygen species superficial envision in each case. These sites were char-(ROS) and reduction in endogenous antioxidant species acterized by abundant expression of HLA-DRa antigen on [33] . ROS also serve as potent chemoattractants for both inflammatory cells and adjacent smooth muscle cells, inflammatory cells [34] .
suggesting an acute inflammatory reaction. Work by Work from several laboratories has shown the presence Warner et al. [43] showed that the cytokine IFN-g could of chronically activated T-lymphocytes within the human induce the expression of HLA-DRa in cultures of human atheroma [35, 36] , which may have important implications smooth muscle cells. Rekhter et al. [44] documented an in plaque rupture. The inflammatory cells inhibit collagen inverse correlation between T-lymphocytes and interarterisynthesis and may thus participate in the conversion of a al collagen protein in human atheroma. It may be hypothstable to unstable plaque-which ruptures under appropriate esized that the deficiency of collagen renders the vulnerhemodynamic stress. Inflammatory cells as well as endoable plaque weak and prone to rupture. thelial cells are powerful sources of ROS, which adversely
The thrombus that forms in the narrowed stenotic influence endothelial integrity [37] . Superoxide anions, in atherosclerotic arteries following plaque rupture is initiated particular, cause breakdown of NO [21] , with resultant as platelets adhere to the subendothelial layers and undergo vasospasm. Deficiency of NO, a potent inhibitor of platelet activation. The platelet-initiated white thrombus enlarges aggregation [21] , promotes platelet accumulation and with the incorporation of red blood cells and fibrin. The activation. ROS also cause injury to the endothelial cells inflammatory cells are often seen in the enlarging throm- [37] and enlarge interstitial space inducing leakage of bus, and their role continues to be of much interest in blood constituents into the subendothelial layers. Activated many laboratories. inflammatory cells elicit elastase (and other proteolytic On one hand, activation of platelets is potentiated by enzymes) and arachidonate metabolites which cause endo-PMN-derived ROS [45] and peptido-leukotrienes [46] .
Thromboxane A generation by platelets is also potentiated may not be possible to delineate patients in whom inflam-2 by leukotrienes. Products of platelet activation, such as mation is a dominant player from those in whom inflamserotonin, epinephrine and ADP/ATP as well as plateletmation is less important. Similarly, the role of dynamic derived growth factor stimulate PMN adhesion at convasoconstriction in the presence of rapidly forming thromcentrations below those usually present in human serum bus may not be easy to define in many patients. and well below those present in the blood vessels at sites of platelet accumulation [47] . As evidence for platelet-PMN interaction, inhibitors of PMN lipoxygenase reduce 4. Inflammation in patients with ischemic heart thrombus size [48] , and platelet deposition is facilitated by disease PMNs [49] .
On the other hand, PMNs inhibit platelet reactivity by Inflammation, as evident by high white blood cell count multiple mechanisms which may be relevant in thromand high erythrocyte sedimentation rate, has been thought boregulation. First, human PMNs synthesize NO from to reflect the body's response to tissue injury in patients L-arginine, that elevates cGMP levels in platelets and thus with acute myocardial ischemia. It is only relatively recent inhibits platelet aggregation [50]. Valles et al. [51] have that inflammation has been considered unphysiologic, shown NO-independent PMN-induced inhibition of platelet especially with the knowledge gained from pathologic aggregation in response to thrombin, collagen or calcium studies in animals subjected to coronary artery occlusion ionophore A23187. Another mechanism by which PMNs and reperfusion strategies. Whereas there is substantial inhibit platelet aggregation involves PMN-derived elastase evidence that PMN accumulation and activation (acute acting on platelet membrane glycoproteins [49] . PMNs inflammation) occurs in the reperfused regions and can have also been found to contain ADPase activity [52, 53] result in substantial extension of necrosis, there is a paucity which could metabolize ADP released from platelets or of data on leukocyte biology in humans with IHD. injured tissues, thereby inhibiting platelet recruitment.
Understanding leukocyte function and the role of inflamTogether these observations suggest that platelet-PMN matory state in patients with stable IHD may be useful in interactions may limit the size of growing thrombus.
devising preventive and therapeutic strategies. A delicate balance between platelet-PMNs and vascular tissue-derived substances could determine if the thrombus 4.1. Stable /unstable ischemic heart disease will form, and once formed if it will be stable or unstable. In many instances the thrombus is unstable, forms repetiStudies by several investigators [55, 56] have suggested tively, and the only evidence of repeated episodes of that total leukocyte count correlates with the extent and thrombosis may be evident at autopsy. The episodic and severity of coronary atherosclerosis as determined by repetitive formation of thrombus and occurrence of thromcoronary angiography, and the initial leukocyte count bolysis will cause deposition of PMNs in the reperfused during acute myocardial infarction predicts the frequency myocardium as well as in the walls of the affected blood of early ventricular fibrillation. Berliner et al. [57] in 1986 vessel. PMN infiltration in the reperfused myocardium and showed that peripheral PMN activation correlates with the their activation will lead to the 'no-reflow' phenomenon, severity of IHD. release of ROS, proteolytic enzymes and arachidonate More detailed information became available subsequentmetabolites, myocardial stunning and arrhythmias [4] . The ly by work done in our and others' laboratories. In a study state of acute inflammation may also facilitate progression of patients with stable angina pectoris, others with unstable of atherosclerosis by mechanisms described earlier.
angina pectoris and age-matched control subjects [58] , Braunwald [54] has recently classified unstable angina PMN chemotactic activity was found to markedly inresulting from different etiologies: thrombosis, mechanical creased in patients with angina pectoris in basal state and it obstruction, dynamic obstruction (vasospasm), inflammaincreased further upon stimulation with f-MLP. In contrast, tion, and increased myocardial oxygen demand. He indibasal PMN chemotactic activity was maximally increased cates that the most common form is due to moderate in the basal state and it did not further increase with f-MLP obstruction with overlying thrombosis, a relatively unin patients with unstable angina. In stable angina patients common forms involves dynamic vasoconstriction, and the PMN LTB generation (in response to calcium ionophore 4 third form involves a combination of thrombosis, me-A23187) was twice the value in the control subjects, but it chanical obstruction and inflammation of the vessel wall.
was not increased in patients with unstable angina. On This classification may be important, but does not take into transmission electron microscopy, PMNs from patients account the complex but variable contribution of different with unstable angina had pseudopod formation, intracytopconstituents of the thrombus itself which regulate the lasmic vacuoles and intercellular adhesion, whereas those stability of the thrombus. Further, the aggregating platelets from control subjects and stable angina patients had may release potent vasoconstrictor species thromboxane smooth borders and lack of pseudopod formation and A and serotonin which may induce some degree of intercellular attachment. Furthermore, PMN elastase activi-2 dynamic vasoconstriction. From a clinical point of view, it ty, measured as fibrin(ogen) split product, peptide Bb 30-43, was markedly elevated in patients with unstable low L-selectin levels, we measured expression of L-selecangina, but not in those with stable angina [58, 59] . tin in vitro following stimulation with f-MLP, and found a Collectively, these observations indicate that PMNs from quantitative decrease in L-selectin expression on lymphostable IHD patients have increased ability to migrate cytes, monocytes and PMNs, a change qualitatively similar (chemotaxis) and to release arachidonate metabolites (5- to that in PMNs from IHD patients. In our opinion, these lipoxygenase activity), whereas PMNs in unstable IHD are data suggest a state of chronic activation of endothelial already maximally activated with no further increase in cells, smooth muscle cells and monocytes (sources of their functional response upon exposure to f-MLP or ICAM-1) in IHD patients. Down-regulation of L-selectin calcium ionophore A23187. Others have also examined release implies a continuous activation of PMNs followed leukocyte elastase activity in patients with IHD and made by their exhaustion in IHD. similar observations. For example, Amaro et al. [60] found Hwang et al. [64] measured circulating E-selectin, elastase activity to be elevated in patients with IHD with VCAM-1 and ICAM-1 levels in blood samples from 204 greater activity in complex-plaque CAD than in those with patients with CAD and 316 control subjects from the simple-plaque disease.
Atherosclerosis Risk in Communities (ARIC) study, and The 'hyperactivity' of PMNs in patients with stable described elevated levels of E-selectin and ICAM-1, angina may relate to 'priming' of cells in response to whereas VCAM-1 levels were not different. They sugplatelet activating factor (PAF), or some other stimuli.
gested that plasma levels of ICAM-1 and E-selectin may Werthen et al. [61] have shown that small concentrations serve as molecular markers of atherosclerosis and developof PAF enhance PMN superoxide production. These early ment of CAD independent of other risk factors. However, observations can also be translated to imply that enhanced a Japanese group [65] found no increase in circulating PMN activity provides a pathophysiologic milieu for the E-selectin levels, but a significant increase in ICAM-1 progression of stable to unstable IHD. levels in patients with CAD with no difference between To determine if cytokine production is increased in those with stable or unstable angina. Another study by patients with IHD, we conducted a study in patients with Mazonne et al. [66] showed increased expression of Mac-1 stable and unstable angina [62] , in which mononuclear (CD11b / CD18), the adhesive ligand for ICAM-1, on cells from patients' blood samples were incubated with PMNs and monocytes recovered from the coronary venous concavalin A for up to 48 h, and release of TNFa and blood of patients with unstable angina but not in patients IFN-g was measured by ELISA. Basal as well as conwith stable angina or those with atypical chest pain. cavalin A-stimulated cytokine production was several-fold
The major arachidonic acid metabolic pathway in PMNs higher in mononuclear cells from patients with stable as is the presence of 5-lipoxygenase enzymes resulting in the well as unstable IHD as compared to those from control formation of leukotrienes with vasoconstrictor and vascular subjects with no difference in cytokine values in the two permeability enhancing effects. de Servi et al.
[67] pregroups of patients. To determine the significance of sented evidence for transcardiac release of leukotriene C 4 enhanced cytokine release, PMNs from patients with IHD in patients with CAD as well as for prior 'exhaustion' of and control subjects were incubated with TNFa and IFN-g.
PMNs from continuous in vivo activation. Carry et al. [68] Whereas PMN superoxide anion production increased subsequently, by measuring urinary metabolites of arachidramatically in response to cytokines in control subjects, donic acid, provided evidence that 5-lipoxygenase activity the basal value was 2-4 times greater in IHD patients with is increased in patients with unstable coronary disease, no additional increase after incubation with exogenous with a decline in the activity of the enzyme by Day 3, at cytokines. These data can be interpreted to imply an which time chest pain had resolved. These observations increase in cytokine release from mononuclear cells causes were subsequently confirmed by Takase et al. [69] . persistent stimulation of PMNs in IHD. These data comAnother major function of PMNs is to generate ROSplement and provide support for previous studies [58] which, in pathologic concentrations, can induce endothelial suggesting chronic inflammation in IHD with acute exinjury [37] . As mentioned earlier, several studies have acerbation during instability of disease.
shown upregulation of PMN ROS generation in patients In the next series of studies on the biology of leukocytes with IHD. Wahi et al. [70] measured ROS generation in in IHD, we measured circulating form of intercellular patients with acute myocardial infarction and others with adhesion molecule-1 (cICAM-1) and L-selectin in patients stable angina. Whereas ROS generation was increased in with stable angina, unstable angina, or acute myocardial patients with acute myocardial infarction at the time of infarction besides the control group [63] . cICAM-1 levels presentation, the levels fell by 72 h. Importantly, there was were similarly and significantly higher in all patients with no correlation between creatine kinase-MB and ROS IHD compared with those in the control groups. There was release. no correlation of cICAM-1 levels with the extent of CAD or total leukocyte counts. In contrast, the circulating L-4.2. Coronary artery interventions selectin levels were significantly lower in IHD patients compared with the control group. To determine the basis of
One of the models of coronary occlusion-reperfusion and vascular injury in humans is percutaneous transluminal marked in subjects with the highest levels of C-reactive coronary angioplasty (PTCA). Several investigators have protein and serum amyloid A. examined the influence of PTCA on indices of inflammaTwo Japanese groups have directly examined the role of tion using a variety of techniques. Ikeda et al. [5] found a PMNs and their activation in human models of ischemic marked increase in surface expression of PMN CD11b injury. Chiba et al. [78] evaluated the effects of PMN adhesion molecules, PMA-stimulated ROS release, and depletion on reperfusion injury during cardiopulmonary elastase generation in the coronary venous blood, indicatbypass. They found that the mean creatine kinase activity ing that PTCA induces PMN activation. Serrano et al. [71] was lower, need for catecholamines lower, and cardiac showed that 15 min after PTCA there was an increase in index higher in the PMN-depleted group of patients. In CD18 and CD11b expression and a decrease in L-selective another study, Murohara et al. [79] examined the effect of expression on PMNs. PMN superoxide production and superoxide dismutase (SOD) administration on reperfusion aggregation decreased following PTCA, indicating prior arrhythmias and left ventricular function in patients underintravascular activation of PMNs. Inoue et al. [7] stratified going thrombolysis in anterior wall myocardial infarction, PTCA patients into restenosis and no-restenosis groups and and found that SOD administration significantly decreased observed that CD11b / 18 expression on PMNs was greater reperfusion arrhythmias and preserved left ventricular in those who developed restenosis. Similar results were function. However, in a later large multicentered study, the obtained by Mickelson et al. [6] . Baj et al. [72] showed use of SOD was not shown to be beneficial in preventing that expression of PMN adhesion molecules CD11c incoronary artery restenosis in patients undergoing PTCA creased with a significant positive correlation between [80] . inflation time and CD11c expression immediately after Recent studies suggest that platelet GPIIb / IIIa blockers, reperfusion. PTCA also triggers intracoronary leukotriene which significantly improve outcome in patients with release [73] .
unstable angina, may interfere with a b receptors, and
attenuate inflammatory reaction may be specifically true of abciximab [81] . Two other studies in this regard are noteworthy. Pepine 5. Clinical studies directed at modulation of et al. [82] postulated that steroids may be useful in inflammation in IHD preventing restenosis after PTCA in view of their potent effect on accumulation and activation of inflammatory The provocative studies in animals and the observations cells; however, in a large multicentered trial in 915 patients in humans definitely suggest that chronic inflammation is given placebo or 1 g methylprednisolone 2-24 h before present in patients with IHD. Exacerbation of markers of PTCA, they found no difference in restenosis rate between PMN activation is also present in unstable IHD.
the two groups. An important and noteworthy study in this regard is by
In another unpublished study, effect of strategy to block Liuzzo et al. [74] who found that the acute phase reactants, PMN rolling and adhesion by using P-selectin blockade C-reactive protein and serum amyloid A protein, were early during reperfusion was examined in patients underelevated in most patients with unstable angina and recent going thrombolysis. While P-selective blockade has been acute myocardial infarction. Elevated levels of these acute found to be very beneficial in decreasing reperfusion injury phase reactants at the time of hospital admission were in a variety of animal models and in in vitro studies [15] , predictors of poor outcome in patients with unstable IHD.
this clinical study failed to show any benefit in patients Ridker et al. [75] recently reported on the plasma Cwith acute unstable IHD. reactive protein levels in the participants of the Physicians' Health Study and found that the level of C-reactive protein was an independent significant predictor of future myocar-6. Integration of studies on inflammation in IHD dial infarction and ischemic stroke. Importantly, the use of aspirin was associated with marked reduction in the risk of
The very interesting data presented thus far in animal myocardial infarction in men in the highest quartile models as well as in humans with atherosclerosis clearly (plasma C-reactive protein), but with a small insignificant suggest that inflammation is part and parcel of atheroreduction in the lowest quartile. These observations indisclerosis. There is clear evidence that inflammation is cate that the major beneficial effect of aspirin may be present in the blood vessels of patients with IHD. Further, derived from its anti-inflammatory effect [76] . Ridker et al. laboratory studies suggest that simple tests such as ele- [77] also examined if the decrease in risk of cardiac events vated white cell count and PMN count in blood can predict after myocardial infarction with pravastatin correlated with patient outcome. The inflammatory cells are continuously the presence of inflammation. They confirmed that the activated in IHD, with acute exacerbation during arterial highest risk was in those with evidence of inflammation injury (PTCA), intravascular thrombosis (acute coronary (C-reactive protein and serum amyloid A). Importantly, the syndromes) and cardiomyocyte injury (myocardial infarcreduction in cardiac events with pravastatin was most tion). 
